Table of contents
October 2014 - Volume 85 - 10
Neurodegeneration
Epilepsy
Multiple sclerosis
Neuropsychiatry
- Research paper: Attention! A good bedside test for delirium? (25 February, 2014)
Neuromuscular
Movement disorders
Historical note
PostScript
ABN Abstracts
- 001: NATIONAL AUDIT OF SEIZURE MANAGEMENT IN HOSPITALS 2 (NASH2) (9 September, 2014)
- 002: STATUS EPILEPTICUS INCIDENCE AND PROGNOSIS 1995–2013 (9 September, 2014)
- 003: TUBULINOPATHIES IN MALFORMATIONS OF THE CEREBRAL CORTEX (9 September, 2014)
- 004: EPILEPSY PREVALENCE, INCIDENCE AND SOCIOECONOMIC DEPRIVATION (9 September, 2014)
- 005: HYPERCONNECTIVITY IN JME—A NETWORK ANALYSIS (9 September, 2014)
- 006: WHICH GENETIC PATHWAYS UNDERLIE PHARMACORESISTANT EPILEPSY? (9 September, 2014)
- 007: THE ROLE OF CHRONIC INFLAMMATION ON AMYLOID BURDEN IN MS (9 September, 2014)
- 008: ALEMTUZUMAB: LONG TERM FOLLOW-UP IN A SINGLE CENTRE COHORT (9 September, 2014)
- 009: 3T T2* MRI DISTINGUISHES MS FROM MICROANGIOPATHIC LESIONS (9 September, 2014)
- 010: NO TEMPORAL EFFECT ON DISABILITY IN MULTIPLE SCLEROSIS (9 September, 2014)
- 011: COMPLEMENT ACTIVATION IN MS: AN IMMUNOHISTOCHEMICAL ANALYSIS (9 September, 2014)
- 012: THE UK MS RISK-SHARING SCHEME: RESULTS FOR YEARS 4 AND 6 (9 September, 2014)
- 013: AN ASSESSMENT TOOL FOR MEASURING EFFICACY OF IVIG IN CIDP (9 September, 2014)
- 014: CARE OF GUILLAIN-BARRé SYNDROME AFTER ICU DISCHARGE (9 September, 2014)
- 015: NEUROLOGISTS ADHERENCE TO GUIDELINES WHEN PRESCRIBING PLEX (9 September, 2014)
- 016: VGKC LIMBIC ENCEPHALITIS—A CASE SERIES (9 September, 2014)
- 017: RETROGRADE AMNESIA FOLLOWING AUTOIMMUNE LIMBIC ENCEPHALITIS (9 September, 2014)
- 018: MOG-IGG IN NMO AND NMO-LIKE DISORDERS (9 September, 2014)
- 019: AUDIT ON IN-HOSPITAL PRESCRIBING IN PARKINSON'S DISEASE (9 September, 2014)
- 020: PARKINSON'S DISEASE: HOW MANY FORMS ARE THERE? (9 September, 2014)
- 021: PD REHAB RCT OF PHYSIOTHERAPY AND OT IN PARKINSON'S DISEASE (9 September, 2014)
- 022: INCIDENCE OF DEMENTIA IN PARKINSON'S DISEASE: THE PINE STUDY (9 September, 2014)
- 023: QUANTIFYING MUTANT HUNTINGTIN IN HUNTINGTON'S DISEASE CSF (9 September, 2014)
- 024: WHY DOES DOPAMINE DEPLETION HAMPER MOVEMENT? (9 September, 2014)
- 025: NEUROBORELLIOSIS IN SOUTH WEST ENGLAND (9 September, 2014)
- 026: MITOCHONDRIAL MUTATIONS IN HIV-ASSOCIATED SENSORY NEUROPATHY (9 September, 2014)
- 027: ICNARC STUDY OF MORTALITY IN NEUROLOGICAL PATIENTS ON ICU (9 September, 2014)
- 028: FUNCTIONAL MEMORY DISORDER; REVIEW FROM A MEMORY CLINIC (9 September, 2014)
- 029: PERCUTANEOUS TIBIAL NERVE STIMULATION FOR OVERACTIVE BLADDER (9 September, 2014)
- 030: THE CLINICAL AND GENETIC SPECTRUM OF HEMIPLEGIC MIGRAINE (9 September, 2014)
- 032: SEE NO EVIL, HEAR NO EVIL, SPEAK NO EVIL… KEEP IT A SICRET (9 September, 2014)
- 033: THUNDERCLAP HEADACHE—NOT A RASH DIAGNOSIS (9 September, 2014)
- 034: IT'S NO LAUGHING MATTER (9 September, 2014)
- 035: WHY THE LONG FACE? (9 September, 2014)
- 036: THE 17 SYNDROME (9 September, 2014)
- 037: AN OCCULT DISEASE… AND ONE THAT CHANGED MY PRACTISE (9 September, 2014)
- 040: AN AUDIT OF PARKINSON'S DISEASE MANAGEMENT (9 September, 2014)
- 041: A NOVEL METHOD TO IMPROVE NEUROLOGICAL DISEASE SURVEILLANCE (9 September, 2014)
- 042: A PROSPECTIVE AUDIT OF PRESCRIBING IN PARKINSON'S DISEASE (9 September, 2014)
- 043: SERVICE EVALUATION OF DEMENTIA SCREENING IN OLDER INPATIENTS (9 September, 2014)
- 044: AUGMENTED REALITY DYNAMIC HOLOGRAPHY FOR NEUROLOGY (9 September, 2014)
- 045: THE FATE OF ABSTRACTS AT THE ABN (9 September, 2014)
- 046: SURVEY OF UK MEDICAL STUDENTS ON THE PERCEPTION OF NEUROLOGY (9 September, 2014)
- 047: SHORT-VIDEO EEG IN DIAGNOSING NON-EPILEPTIC ATTACK DISORDER (9 September, 2014)
- 048: CAN A RAPID ACCESS NEUROLOGY CLINIC REDUCE A&E ADMISSIONS? (9 September, 2014)
- 049: THE ELECTROENCEPHALOGRAM: MISUSED AND MISUNDERSTOOD? (9 September, 2014)
- 050: DEVELOPING A NEUROLOGY MENTORING PROGRAMME FOR TRAINEES (9 September, 2014)
- 051: AN AUDIT OF TRANSIENT LOSS OF CONSCIOUSNESS (9 September, 2014)
- 052: 6CIT FOR DETECTION OF DEMENTIA AND COGNITIVE IMPAIRMENT (9 September, 2014)
- 053: APRAXIA AND ASSOCIATED FEATURES AT PRESENTATION IN DEMENTIA (9 September, 2014)
- 054: LONGITUDINAL IMAGING AND ANALYSIS OF TAU-EXPRESSING NEURONS (9 September, 2014)
- 055: HUMOUR PROCESSING IN FRONTOTEMPORAL LOBAR DEGENERATIONS (9 September, 2014)
- 056: IS COGNITIVE SCREENING IN PRIMARY CARE CHANGING? (9 September, 2014)
- 057: ADULT ONSET LEUKOENCEPHALOPATHY DUE TO CSF1R GENE MUTATION (9 September, 2014)
- 058: ACE AND ACE-R FOR DIAGNOSIS OF DEMENTIA: A META-ANALYSIS (9 September, 2014)
- 059: PREVALENCE OF SLEEP DISORDERS IN A MEMORY CLINIC POPULATION (9 September, 2014)
- 060: MOCA SUBSCORES TO DIAGNOSE DEMENTIA SUBTYPES: INITIAL STUDY (9 September, 2014)
- 061: NEUROINFLAMMATION AND AMYLOID PATHOLOGY AFTER TBI (9 September, 2014)
- 062: ACCURACY OF AD8 SCREENING QUESTIONNAIRE FOR DEMENTIA (9 September, 2014)
- 063: GELASTIC SEIZURES: NO LAUGHING MATTER (9 September, 2014)
- 064: SLEEP AND MEMORY CONSOLIDATION IN TEA (9 September, 2014)
- 065: WHAT CONTRIBUTES TO MEMORY LOSS IN EPILEPTIC PATIENTS? (9 September, 2014)
- 069: BETTER LATE THAN NEVER? (9 September, 2014)
- 070: STATUS EPILEPTICUS IN THE UNIVERSITY HOSPITAL OF WALES (9 September, 2014)
- 071: SHER-LOC IN THE FIRST SEIZURE CLINIC (9 September, 2014)
- 072: EPILEPSY SERVICE INNOVATION–SWITCHING TO OPEN ACCESS (9 September, 2014)
- 073: FACTORS ASSOCIATED WITH EMERGENCY ATTENDANCES FOR EPILEPSY (9 September, 2014)
- 075: AN INTERVENTION TRIAL FOR PEOPLE WITH EPILEPSY ATTENDING A&E (9 September, 2014)
- 076: SELF-MANAGEMENT EDUCATION FOR EPILEPSY: AN RCT PROTOCOL (9 September, 2014)
- 077: EXTERNAL TRIGEMINAL NERVE STIMULATION (ETNS) FOR EPILEPSY (9 September, 2014)
- 078: EPILEPSY PREVALENCE AND SOCIOECONOMIC DEPRIVATION IN ENGLAND (9 September, 2014)
- 079: COMPULSIVE VERSIFYING IN TRANSIENT EPILEPTIC AMNESIA (9 September, 2014)
- 080: EAR WORMS AND AUDITORY CHARLES BONNET SYNDROME (9 September, 2014)
- 081: ADULT LEUKODYSTROPHY: MULTI-DISCIPLINARY STRUCTURED APPROACH (9 September, 2014)
- 082: A NATIONWIDE ANALYSIS OF LITIGATION IN NEUROLOGICAL PRACTICE (9 September, 2014)
- 083: ALARM BELLS RINGING FOR MELKERSSON-ROSENTHAL SYNDROME? (9 September, 2014)
- 084: HIPPOCAMPAL CONNECTIVITY AND POST-TRAUMATIC AMNESIA (9 September, 2014)
- 085: THE USE OF BOTULINUM TOXIN IN WOMEN WITH FOWLER'S SYNDROME (9 September, 2014)
- 086: POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME IN PUERPERIUM (9 September, 2014)
- 087: YOU CANNOT BE SIRIUS! (9 September, 2014)
- 088: A TALE OF THE UNEXPECTED: ISOLATED FRONTAL LOBE AMYLOIDOMA (9 September, 2014)
- 090: BRAIN STEM AUDITORY AGNOSIA: AUDITORY CORTEX ACTIVATED TDCS (9 September, 2014)
- 091: A CLEAN PAIR OF HEELS; LEUKODYSTROPHY IN A 40 YEAR OLD MALE (9 September, 2014)
- 092: MOVING TO CONNECTIVE TISSUE DISEASE (9 September, 2014)
- 093: INVESTIGATING AUTISTIC TRAITS AND SIMPLE SENSORY PROCESSING (9 September, 2014)
- 094: AN UNUSUAL DIAGNOSIS OF PINPOINT TONIC PUPILS (9 September, 2014)
- 095: EVOLVING BRAIN LESION: CAAN'T MAKE A DIAGNOSIS (9 September, 2014)
- 096: STATUS EPILEPTICUS SECONDARY TO UNUSUAL ENCEPHALOPATHY (9 September, 2014)
- 097: SYMPTOMS OF MITOCHONDRIAL DISEASE FALLING ON DEAF EARS (9 September, 2014)
- 098: CARDIAC FEATURES IN ADULTS WITH ALTERNATING HEMIPLEGIA (9 September, 2014)
- 099: SUDDEN UNEXPECTED DEATH IN ADULTS WITH M. 3243A>G MUTATION (9 September, 2014)
- 100: THE MULTIDISCIPLINARY ADULT ATAXIA TELANGIECTASIA SERVICE (9 September, 2014)
- 101: INTRACRANIAL HYPERTENSION DUE TO ARTERIOVENOUS MALFORMATION (9 September, 2014)
- 102: THUNDERCLAP HEADACHE: ARE WE INVESTIGATING SUFFICIENTLY? (9 September, 2014)
- 103: THUNDERCLAP HEADACHE: ARE WE INVESTIGATING SUFFICIENTLY? (9 September, 2014)
- 104: HEADACHE DETERMINES QUALITY OF LIFE IN IIH (9 September, 2014)
- 105: AUTO-REGULATION ICP IN IIH DUE TO CHRONIC CSF LEAK (9 September, 2014)
- 106: LAUGHING ‘TIL IT HURTS: A CURIOUS CASE OF MIRTH AND MIGRAINE (9 September, 2014)
- 107: PATIENTS’ IDEAS AND CHOICES ABOUT THE MANAGEMENT OF HEADACHE (9 September, 2014)
- 108: PSYCHOLOGICAL INTERVENTIONS FOR MIGRAINE: SYSTEMATIC REVIEW (9 September, 2014)
- 109: PATHOLOGICAL MECHANISMS OF GLYCINE RECEPTOR ANTIBODIES (9 September, 2014)
- 110: TWO CASES WITH AN IMPORTANT REMINDER (9 September, 2014)
- 111: FROM ATAXIA TO BILATERAL FACIAL PALSY DUE TO ONE VIRUS (9 September, 2014)
- 112: IMMUNOCOMPETENT PML—AN IMMUNOLOGICAL SCOTOMA? (9 September, 2014)
- 113: THE DIAGNOSTIC UTILITY OF RT-QUIC IN SPORADIC CJD (9 September, 2014)
- 114: LISTERIA RHOMBENCEPHALITIS—AN EVOLVING BRAINSTEM SYNDROME (9 September, 2014)
- 115: H1N1 ENCEPHALOPATHY: SUPPORT FOR AUTOIMMUNE PATHOGENESIS (9 September, 2014)
- 116: ONE NIGHT WITH VENUS, A LIFETIME WITH MARS (9 September, 2014)
- 117: THE ‘GREAT IMITATOR’: AN UNEXPECTED CASE OF NEUROSYPHILIS (9 September, 2014)
- 118: HERPES SIMPLEX TYPE 2 ASSOCIATED NEUROLOGICAL SYNDROMES (9 September, 2014)
- 119: A CURIOUS CASE OF URINARY RETENTION (9 September, 2014)
- 120: MULTI-PARAMETER MRI ANALYSIS IN THE NATIONAL PRION COHORT (9 September, 2014)
- 121: CASE REPORT: HEPATITIS B INDUCED NEURO-INFLAMMATION (9 September, 2014)
- 122: DON'T BE REASSURED BY AN UNDETECTABLE SERUM HIV VIRAL LOAD (9 September, 2014)
- 123: A RASH DECISION? (9 September, 2014)
- 124: THE BBB IN ENCEPHALITIS: INFLAMMATION & A ROLE FOR STEROIDS? (9 September, 2014)
- 125: SPINAL CORD GLUTAMATE-GLUTAMINE IS ELEVATED IN MS RELAPSE (9 September, 2014)
- 126: STREAMS: PRELIMINARY RESULTS FROM A PHASE II TRIAL (9 September, 2014)
- 127: A MULTI-MODAL NEUROPHYSIOLOGICAL EVALUATION OF PPMS (9 September, 2014)
- 128: DESIGN AND BASELINE CHARACTERISTICS OF PASSAGE AND UK UPDATE (9 September, 2014)
- 129: AMILORIDE CLINICAL TRIAL IN OPTIC NEURITIS: TRIAL PARADIGM (9 September, 2014)
- 130: THE PSYCHOLOGICAL DETERMINANTS OF JOB RETENTION IN MS (9 September, 2014)
- 132: TREATING GERSTMANN'S SYNDROME WITH NATALIZUMAB (9 September, 2014)
- 134: DEPRESSION IN MS: A SYSTEMATIC REVIEW AND META-ANALYSIS (9 September, 2014)
- 135: A CORTICOCENTRIC MODEL FOR MS PATHOGENESIS (9 September, 2014)
- 136: AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION IN MS (9 September, 2014)
- 137: NATALIZUMAB FOR RELAPSING-REMITTING MS IN THE UK TOP COHORT (9 September, 2014)
- 138: BRAIN VOLUME CHANGE AND DISABILITY IN FINGOLIMOD TRIALS (9 September, 2014)
- 139: RESPONSIVENESS OF MSMSS IN PROGRESSIVE MULTIPLE SCLEROSIS (9 September, 2014)
- 140: CANCER RISK IN MULTIPLE SCLEROSIS PATIENTS TAKING CLADRIBINE (9 September, 2014)
- 141: NETWORK EFFICIENCY AND COGNITIVE DEFICITS IN MS (9 September, 2014)
- 142: THE CARDIFF MS DMT MDT: QUALITY ASSURING TREATMENT DECISIONS (9 September, 2014)
- 143: ACTIMUS—PHASE II CELL THERAPY TRIAL IN PROGRESSIVE MS (9 September, 2014)
- 144: TERIFLUNOMIDE IN CLINICAL PRACTICE: TERI-PRO STUDY DESIGN (9 September, 2014)
- 145: ASSOCIATING AUTOANTIBODIES WITH CLINICAL FEATURES IN MS (9 September, 2014)
- 146: BRAIN ATROPHY AND DISEASE-FREE STATUS OVER 4 YEARS OF FREEDOMS STUDY (9 September, 2014)
- 147: SWITCHING THERAPY TO FINGOLIMOD IMPROVES CLINICAL AND MRI OUTCOMES (9 September, 2014)
- 148: FINGOLIMOD IN NEWCASTLE: THE FIRST 100 PATIENTS' EXPERIENCE (9 September, 2014)
- 149: FUNCTIONAL HUMAN ES-DERIVED OPCS AT LOW OXYGEN (9 September, 2014)
- 150: TERIFLUNOMIDE IN EARLY STAGE MS: RESULTS FROM TOPIC (9 September, 2014)
- 151: MANAGEMENT OF UK FINGOLIMOD FIRST DOSE OBSERVATION (FDO) (9 September, 2014)
- 152: PREGNANCY OUTCOMES FROM TERIFLUNOMIDE CLINICAL STUDIES (9 September, 2014)
- 153: CD34+ STEM CELL MOBILISATION IN MS TREATMENT AND RELAPSE (9 September, 2014)
- 154: TREATMENT OF ATYPICAL CNS INFLAMMATION WITH MITOXANTRONE (9 September, 2014)
- 155: RELAPSING AQP4 ANTIBODY NEGATIVE NMO WITH MOG ANTIBODIES (9 September, 2014)
- 156: MS TYPICAL SPINAL CORD AND BRAIN LESIONS IN NMO—2 EXAMPLES (9 September, 2014)
- 157: IVIG IN NMO REFRACTORY/INTOLERANT TO RITUXIMAB (9 September, 2014)
- 158: CAA-RELATED INFLAMMATION: AN ELUSIVE DIAGNOSIS (9 September, 2014)
- 159: STEROID RESPONSIVE CEREBRAL AMYLOID ANGIOPATHY (9 September, 2014)
- 160: INTERNATIONAL CONSENSUS PROJECT: NEURO-BEHCET DISEASE (9 September, 2014)
- 161: AN EXTENDED CLIPPERS PHENOTYPE (9 September, 2014)
- 162: EFFECT OF TYSABRI AND AQP4-IGG ON AN IN-VITRO MODEL OF BBB (9 September, 2014)
- 163: CONSEQUENCES OF COGNITIVE SYMPTOMS ON WELL-BEING IN NMO (9 September, 2014)
- 164: FREQUENCY OF BLADDER, BOWEL AND SEXUAL DYSFUNCTION IN NMO (9 September, 2014)
- 166: THERAPEUTIC PLASMAPHERESIS: THE SHEFFIELD EXPERIENCE (9 September, 2014)
- 167: CSF IMMUNOPHENOTYPING IN PATIENTS WITH NEUROINFLAMMATORY DISEASE (9 September, 2014)
- 168: A CHALLENGING CASE: SPINAL CORD SARCOIDOSIS (9 September, 2014)
- 169: AN EVALUATION OF THE USEFULNESS OF PERIPHERAL NERVE BIOPSIES (9 September, 2014)
- 170: MFN2 DELETION FOUNDER MUTATION IN THE UK POPULATION (9 September, 2014)
- 171: NEUROPATHY PHENOTYPE IN HEREDITARY TRANSTHYRETIN AMYLOIDOSIS (9 September, 2014)
- 172: CARDIAC AND EXTRACARDIAC AMYLOIDOSIS IN V122I ATTR (9 September, 2014)
- 173: MRI QUANTIFICATION OF FAT GRADIENTS IN CALF MUSCLES IN CMT1A (9 September, 2014)
- 174: BLADDER INVOLVEMENT IN KENNEDY'S DISEASE: A RARE ASSOCIATION (9 September, 2014)
- 175: CHANGING FORMS OF GUILLAIN-BARRé SYNDROME IN NEURO-ICU (9 September, 2014)
- 176: SERONEGATIVE MYASTHENIA GRAVIS-CLINICAL/SEROLOGICAL ASPECTS (9 September, 2014)
- 177: IDIOPATHIC AXONAL NEUROPATHY AND PRIMARY SJöGREN'S SYNDROME (9 September, 2014)
- 178: NON-INVASIVE VENTILATION IN MND PATIENTS IN WEST OF SCOTLAND (9 September, 2014)
- 179: A GENETIC WEAKNESS—PHOENICIAN LEGACY OR CELTIC HERITAGE? (9 September, 2014)
- 180: HOSPITALISATION FOR MYASTHENIA: ARE WE DOING SOMETHING WRONG? (9 September, 2014)
- 181: RAISED VEGF: USEFULNESS IN THE DIAGNOSIS OF POEMS SYNDROME (9 September, 2014)
- 182: ROLE OF COUGH AUGMENTATION IN AMYOTROPHIC LATERAL SCLEROSIS (9 September, 2014)
- 183: SKIN-DEEP; CLUES TO THE CAUSE OF PROXIMAL MYOPATHY (9 September, 2014)
- 184: AN URGENT NEUROLOGY CONSULT FOR SHORTNESS OF BREATH (9 September, 2014)
- 185: CLINICAL MORVAN'S AND ELECTRICAL MND (9 September, 2014)
- 186: A CASE OF RECURRENT MILLER FISHER SYNDROME (9 September, 2014)
- 187: TWO CONCURRENT PARANEOPLASTIC SYNDROMES-USING OCCAM'S RAZOR (9 September, 2014)
- 188: A CASE OF MENINGEAL MELANOMATOSIS (9 September, 2014)
- 189: IS PHYSICAL DISABILITY ASSOCIATED WITH FATIGUE IN GLIOMA? (9 September, 2014)
- 190: PUTTING ORDER INTO INCOORDINATION (9 September, 2014)
- 191: THE TEST IS NEGATIVE: ETHICAL DILEMMA IN UROLOGY & NEUROLOGY (9 September, 2014)
- 193: AN UNDER-RECOGNISED COMPLICATION OF LEUKAEMIA TREATMENT (9 September, 2014)
- 194: THE WIDENING SPECTRUM OF PARANEOPLASTIC DISORDERS: TWO CASES (9 September, 2014)
- 195: POLYNEURITIS CRANIALIS MULTIPLEX DUE TO MYELOMA RELAPSE (9 September, 2014)
- 196: ONDINE'S CURSE (9 September, 2014)
- 197: INTEREST OF EYE MOVEMENT ANALYSIS IN PARKINSONIAN SYNDROMES (9 September, 2014)
- 198: PROGNOSIS IN INCIDENT PARKINSONIAN COHORT: THE PINE STUDY (9 September, 2014)
- 199: THE INFLUENCE OF NICOTINAMIDE ON THE DEVELOPMENT OF NEURONS (9 September, 2014)
- 200: PARKINSON'S SPECIFIC TRIGGER TOOL: DETECTING ADVERSE EVENTS (9 September, 2014)
- 201: PROGRESSION OF DISABILITY IN PD: A SYSTEMATIC REVIEW (9 September, 2014)
- 202: REVIEW: NON-MOTOR SYMPTOMS IN DYSTONIA-PLUS DISORDERS (9 September, 2014)
- 203: MECHANISMS OF DISEASE IN THE HYPEREKPLEXIAS (9 September, 2014)
- 204: RESTING STATE FMRI DISCERNS EARLY PARKINSON'S FROM CONTROLS (9 September, 2014)
- 205: A REFLECTION ON PLASTICITY RESEARCH IN WRITING DYSTONIA (9 September, 2014)
- 207: WHITE MATTER LESIONS AFTER CEREBRAL ANEURYSM COILING (9 September, 2014)
- 208: SPINAL CERVICAL EXTRADURAL HAEMATOMA PRESENTING AS STROKE (9 September, 2014)
- 209: HIV, ANTIRETROVIRAL TREATMENT, AND STROKE IN MALAWIAN ADULTS (9 September, 2014)
- 210: WHATSAPP—AN INNOVATIVE SOLUTION FOR THE STROKE CARE (9 September, 2014)
- 211: WHEN YOU HEAR HOOVES THINK PERCHERON HORSES NOT ZEBRAS (9 September, 2014)
- 212: CTBRAIN MACHINE LEARNING PREDICTS STROKE THROMBOLYSIS RESULT (9 September, 2014)
- 213: PROBABLE BILATERAL POSTERIOR CEREBRAL ARTERY DISSECTION (9 September, 2014)
- 214: NON TRAUMATIC CENTRAL CORD SYNDROME FROM A RARE CAUSE (9 September, 2014)
Editorial commentaries